Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPLES: Long-term safety of Tacrolimus in pediatric atopic dermatitis
NCT00368719Phase 4Withdrawn
- Sponsor
- University of California, Davis
- Start
- Sep 2007
- Modality
- RNA-Targeting Small Molecules
01
Overview
A Phase 4 trial of tacrolimus in atopic dermatitis (AD), sponsored by University of California, Davis. Planned start Sep 2007; status: withdrawn.
02
Drugs
tacrolimus
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00368719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368719.